SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-091094
Filing Date
2020-03-30
Accepted
2020-03-30 17:13:10
Documents
14
Period of Report
2020-03-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d912653d8k.htm   iXBRL 8-K 27178
2 EX-99.1 d912653dex991.htm EX-99.1 42840
6 GRAPHIC g912653g0330165236112.jpg GRAPHIC 2448
  Complete submission text file 0001193125-20-091094.txt   205508

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA myok-20200330.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200330_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200330_pre.xml EX-101.PRE 10955
15 EXTRACTED XBRL INSTANCE DOCUMENT d912653d8k_htm.xml XML 3223
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 20758239
SIC: 2834 Pharmaceutical Preparations